Cargando…
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
The relationship between diabetes and COVID-19 is bi-directional: while individuals with diabetes and high blood glucose (hyperglycemia) are predisposed to severe COVID-19, SARS-CoV-2 infection can also cause hyperglycemia and exacerbate underlying metabolic syndrome. Therefore, interventions capabl...
Autores principales: | Zhu, Bibo, Wei, Xiaoqin, Narasimhan, Harish, Qian, Wei, Zhang, Ruixuan, Cheon, In Su, Wu, Yue, Li, Chaofan, Jones, Russell G., Kaplan, Mark H., Vassallo, Robert A., Braciale, Thomas J., Somerville, Lindsay, Colca, Jerry R., Pandey, Akhilesh, Jackson, Patrick E. H., Mann, Barbara J., Krawczyk, Connie M., Sturek, Jeffrey M., Sun, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972900/ https://www.ncbi.nlm.nih.gov/pubmed/36821695 http://dx.doi.org/10.1126/sciimmunol.adf0348 |
Ejemplares similares
-
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017) -
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration
por: Quansah, Emmanuel, et al.
Publicado: (2018) -
Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015) -
Single cell RNA sequencing unravels mechanisms underlying senescence-like phenotypes of alveolar macrophages
por: Wu, Yue, et al.
Publicado: (2023) -
Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)